Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$14.62 - $22.13 $3.98 Million - $6.03 Million
-272,528 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$17.09 - $38.25 $1.38 Million - $3.08 Million
-80,571 Reduced 22.82%
272,528 $5.57 Million
Q3 2018

Nov 14, 2018

BUY
$34.05 - $55.9 $2.73 Million - $4.48 Million
80,071 Added 29.33%
353,099 $13 Million
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $252,037 - $366,030
-6,972 Reduced 2.49%
273,028 $13.7 Million
Q3 2017

Nov 14, 2017

BUY
$14.65 - $19.35 $4.1 Million - $5.42 Million
280,000
280,000 $5.42 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $534M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.